EGFR and non-small cell lung carcinoma: To assess the clinical significance of our findings, we conducted a single‐cell RNA sequencing analysis of publicly available data (GEO: GSE171145).[23] This analysis identified a subset of pericytes within EGFR‐mutated NSCLC patient‐derived tumors that exhibited high IL32 expression (Figure 1H; Figures S1G,H, Supporting Information), predominantly in pericytes compared to other stromal cells like endothelial cells and fibroblasts (Figure S1I, Supporting Information).